Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Nastoupil, Loretta J
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
Taplitz RA
,
Kennedy EB
,
Bow EJ
,
Crews J
,
Gleason C
,
Hawley DK
,
Langston AA
,
Nastoupil LJ
,
Rajotte M
,
Rolston KV
, et al.
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update.
J Clin Oncol. 2018:JCO1800374.
PubMed
Google Scholar
C
Strati P
,
Ahmed S
,
Kebriaei P
,
Nastoupil LJ
,
Claussen CM
,
Watson G
,
Horowitz SB
,
Brown ARain T
,
Do B
,
Rodriguez MA
, et al.
Clinical efficacy of anakinra to mitigate CAR T-cell therapy-associated toxicity in large B-cell lymphoma.
Blood Adv. 2020;4(13):3123-3127.
PubMed
Google Scholar
D
Dreyling M
,
Fowler NH
,
Dickinson M
,
Martínez-López J
,
Kolstad A
,
Butler J
,
Ghosh M
,
Popplewell L
,
Chavez JC
,
Bachy E
, et al.
Durable Response After Tisagenlecleucel in Adults With Relapsed/Refractory Follicular Lymphoma: ELARA Trial Update.
Blood. 2024.
PubMed
Google Scholar
E
Jallouk AP
,
Kui N
,
Sun R
,
Westin JR
,
Steiner RE
,
Nair R
,
Nastoupil LJ
,
Fayad LE
,
Zaki AAl
,
Hawkins M
, et al.
Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy.
Haematologica. 2023.
PubMed
Google Scholar
P
Ahmed N
,
Wesson W
,
Mushtaq MUmair
,
Porter DL
,
Nasta SD
,
Brower J
,
Bachanova V
,
Hu M
,
Nastoupil LJ
,
Oluwole OO
, et al.
Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel (tisa-cel) Recipients for B Cell Non-Hodgkin Lymphoma.
Transplant Cell Ther. 2023.
PubMed
Google Scholar
Strati P
,
Li X
,
Deng Q
,
Marques-Piubelli ML
,
Henderson J
,
Watson G
,
Deaton L
,
Cain T
,
Yang H
,
Ravanmehr V
, et al.
Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cells.
Cell Rep Med. 2023;4(8):101158.
PubMed
Google Scholar
S
Marin D
,
Li Y
,
Basar R
,
Rafei H
,
Daher M
,
Dou J
,
Mohanty V
,
Dede M
,
Nieto Y
,
Uprety N
, et al.
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19 B cell tumors: a phase 1/2 trial.
Nat Med. 2024.
PubMed
Google Scholar
T
Casulo C
,
Larson MC
,
Lunde JJ
,
Habermann TM
,
Lossos IS
,
Wang Y
,
Nastoupil LJ
,
Strouse C
,
Chihara D
,
Martin P
, et al.
Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study.
Lancet Haematol. 2022;9(4):e289-e300.
PubMed
Google Scholar